New York Life Investment Management LLC Viking Therapeutics, Inc. Transaction History
New York Life Investment Management LLC
- $9.63 Billion
- Q3 2024
A detailed history of New York Life Investment Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 11,978 shares of VKTX stock, worth $617,226. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,978
Previous 11,306
5.94%
Holding current value
$617,226
Previous $599,000
26.54%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
473Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$524 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$311 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$241 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$109 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$96.6 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.95B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...